Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

ELEVATE High-Risk PCI Pivotal Study

The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high-risk percutaneous coronary interventions (HR-PCI).

Participants needed: 290
Trial details
Age: 18-88Biological sex: AllType: InterventionalSponsor: Magenta Medical Ltd.Updated: Apr 28, 2026Locations: 29
Eligibility criteria

Non-emergent, percutaneous coronary intervention is planned on at least one sten... [+2]

Cardiogenic shock or acutely decompensated pre-existing chronic heart failure. [+16]

Read more
Status: Recruiting

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.

Participants needed: 10
Trial details
Age: 40-89Biological sex: AllType: InterventionalSponsor: Magenta Medical Ltd.Updated: Feb 27, 2026Locations: 5
Eligibility criteria

Cardiogenic shock of less than 24 hours duration. [+3]

Other causes of shock: hypovolemia, sepsis (any active systemic infection includ... [+21]

Read more